Effect of pilsicainide on atrial electrophysiologic properties in the canine rapid atrial stimulation model.
The heterogeneous process of atrial electrical remodeling (AER) in the canine rapid atrial stimulation model has been previously reported although it has been reported that a sodium channel blocker might suppress the shortening of the atrial effective refractory period (AERP), its effect on long-term electrical remodeling is unknown. In the present study, the effect of pilsicainide on AER was evaluated. The right atrial appendage (RAA) was paced at 400 beats/min for 2 weeks. In the RAA, Bachmann's bundle (BB), the right atrium near the inferior vena cava (IVC) and in the left atrium (LA), AERP, AERP dispersion (AERPd) and the inducibility of atrial fibrillation (AF) were evaluated at several time points of the pacing phase and the recovery phase (1 week). The same protocol was performed during the administration of pilsicainide (4.5 mg/kg per day) and the parameters were compared with the controls. In the control dogs, the AERP was significantly shortened by rapid pacing at all atrial sites studied and the AERP shortening (DeltaAERP) was larger at the RAA and LA sites (p<0.03). However, pilsicainide decreased these DeltaAERPs at all 4 atrial sites. AERPd was increased during the pacing phase whereas it was decreased during the recovery phase in the control dogs. In contrast, this pacing-induced AERPd was attenuated by the administration of pilsicainide. The AF inducibility was highest at the LA site in both groups, and the inducibility was lower in the pilsicainide group than the control group at all atrial sites. During the rapid pacing phase, the ventricular heart rate was significantly lower in the pilsicainide group than the control because of intra-atrial conduction block. In a canine rapid right atrial stimulation model, pilsicainide suppressed the shortening of the AERP at all atrial sites, possibly through the improvement of the hemodynamics as well as the action of the Na - Ca exchanger.
Kojima
Jisho
J
Department of Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan. jisyou@med.kitasato-u.ac.jp
Niwano
Shinichi
S
Moriguchi
Masahiko
M
Ikeda
Kazuko
K
Inuo
Kimiatsu
K
Saito
Junko
J
Izumi
Toru
T
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001281:Atrial Fibrillation / Q000209:etiology; D016275:Atrial Function / Q000187:drug effects*; D002304:Cardiac Pacing, Artificial; D003971:Diastole; D004056:Differential Threshold; D004285:Dogs; D004594:Electrophysiology; D006339:Heart Rate; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D012032:Refractory Period, Electrophysiological; D016276:Ventricular Function
D000889:Anti-Arrhythmia Agents; D008012:Lidocaine; C042288:pilsicainide